9-minute watch
| Talk 3
of 5
ICML: Evolving survival outcomes with CAR T in 2L DLBCL
Defining the unmet need in 2L DLBCL
Dr Michael Dickinson
Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia
Dr Michael Dickinson, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia, summarises the unmet needs in R/R DLBCL, including the eligibility criteria for CAR T and patient populations where CAR T-cells could be effective
